glp 1 eye problems Danny D. | ποΈ Important safety update from the *BMJ*: Emerging evidence and regulatory reviews are prompting new warnings about a potential link Thereβs been a lot of
Description
In addition to their glycemic effects, DPP-4 inhibitors have the potential to decrease bone resorption, increase bone formation, and reduce the incidence of osteoporosis and fractures
But the industry standard range falls in that window
Without changes to lifestyle, weight that took months to shed is rapidly regained once the medication is discontinued, reversing the improvements to metabolic health
Losing weight and keeping it off is a herculean task, which may be what is driving the GLP-1 market
Gallstones in obesity and weight loss
Which direction do you take
